HUTCHMED (China) Ltd (HCM): Total Assets
$1.75B
As of 2025-12-31
+19.4%
3-year compound annual growth
+19.3%
5-year compound annual growth
+22.5%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.75B | +37.6% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $1.27B | -0.4% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $1.28B | +24.3% | 2025-03-19, Balance as of period end |
| 2022-12-31 | $1.03B | -25.0% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $1.37B | +89.6% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $724.12M | +55.7% | 2022-03-03, Balance as of period end |
| 2019-12-31 | $465.12M | -12.6% | 2021-03-04, Balance as of period end |
| 2018-12-31 | $532.12M | -11.0% | 2020-03-03, Balance as of period end |
| 2017-12-31 | $597.93M | +74.6% | 2019-03-11, Balance as of period end |
| 2016-12-31 | $342.44M | +49.1% | 2018-03-12, Balance as of period end |
| 2015-12-31 | $229.60M | n/a | 2017-03-13, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $1.75B | +37.6% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $598.73M | +20.3% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $842.81M | +25.7% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $936.02M | +1.8% |
| Insmed Inc (INSM) | 2025-12-31 | $2.26B | +11.8% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $1.93B | -12.2% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $605.19M | +1.9% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $1.06B | +84.1% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $261.15M | +8.4% |
Compare HCM, ORGO, MIRM, BBIO side by side · Screen every company in Pharmaceutical Preparations ↗